Compare NKTX & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKTX | QIPT |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.8M | 157.2M |
| IPO Year | 2020 | 2012 |
| Metric | NKTX | QIPT |
|---|---|---|
| Price | $2.33 | $3.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $13.25 | $3.83 |
| AVG Volume (30 Days) | ★ 716.3K | 351.3K |
| Earning Date | 01-01-0001 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $245,359,000.00 |
| Revenue This Year | N/A | $28.30 |
| Revenue Next Year | N/A | $1.79 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.31 | $1.37 |
| 52 Week High | $2.74 | $3.63 |
| Indicator | NKTX | QIPT |
|---|---|---|
| Relative Strength Index (RSI) | 60.28 | 77.75 |
| Support Level | $1.95 | $3.55 |
| Resistance Level | $2.42 | $3.54 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 80.39 | 93.33 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.